Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
N Engl J Med. 2019.
PMID: 31566307
Clinical Trial.
Safety and tolerability of spesolimab in patients with ulcerative colitis.
Ferrante M, Irving PM, Selinger CP, D'Haens G, Kuehbacher T, Seidler U, Gropper S, Haeufel T, Forgia S, Danese S, Klaus J, Feagan BG for the spesolimab in UC phase II clinical trial investigators.
Ferrante M, et al. Among authors: haeufel t.
Expert Opin Drug Saf. 2023 Feb;22(2):141-152. doi: 10.1080/14740338.2022.2103536. Epub 2022 Jul 31.
Expert Opin Drug Saf. 2023.
PMID: 35861588
Clinical Trial.
Item in Clipboard
Spesolimab use in generalised pustular psoriasis flares - Authors' reply.
Lebwohl MG, Thoma C, Haeufel T.
Lebwohl MG, et al. Among authors: haeufel t.
Lancet. 2024 Aug 31;404(10455):847-848. doi: 10.1016/S0140-6736(24)01557-5.
Lancet. 2024.
PMID: 39216969
No abstract available.
Item in Clipboard
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study.
Cao G, Yang H, Wang J, Ishida M, Thoma C, Haeufel T, Bossert S, Zhang J.
Cao G, et al. Among authors: haeufel t.
Adv Ther. 2024 Sep;41(9):3557-3568. doi: 10.1007/s12325-024-02940-8. Epub 2024 Jul 22.
Adv Ther. 2024.
PMID: 39039387
Clinical Trial.
Item in Clipboard
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Morita A, Strober B, Burden AD, Choon SE, Anadkat MJ, Marrakchi S, Tsai TF, Gordon KB, Thaçi D, Zheng M, Hu N, Haeufel T, Thoma C, Lebwohl MG.
Morita A, et al. Among authors: haeufel t.
Lancet. 2023 Oct 28;402(10412):1541-1551. doi: 10.1016/S0140-6736(23)01378-8. Epub 2023 Sep 19.
Lancet. 2023.
PMID: 37738999
Clinical Trial.
Item in Clipboard
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.
Burden AD, Bissonnette R, Navarini AA, Murakami M, Morita A, Haeufel T, Ye B, Baehner F, Terui T.
Burden AD, et al. Among authors: haeufel t.
Dermatol Ther (Heidelb). 2023 Oct;13(10):2279-2297. doi: 10.1007/s13555-023-01002-1. Epub 2023 Sep 20.
Dermatol Ther (Heidelb). 2023.
PMID: 37731086
Free PMC article.
Item in Clipboard
Assessment of the Pharmacokinetics and Safety of Spesolimab, a Humanised Anti-interleukin-36 Receptor Monoclonal Antibody, in Healthy Non-Japanese and Japanese Subjects: Results from Phase I Clinical Studies.
Joseph D, Thoma C, Haeufel T, Li X.
Joseph D, et al. Among authors: haeufel t.
Clin Pharmacokinet. 2022 Dec;61(12):1771-1787. doi: 10.1007/s40262-022-01176-5. Epub 2022 Dec 1.
Clin Pharmacokinet. 2022.
PMID: 36451029
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite